Dr Mark Kurtser of MD Medical Group speaks on the role of the private sector in developing Russia’s healthcare system
Dr Mark Kurtser, Chairman of the Board of Directors at MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), Russia’s leading provider of private women’s and children’s healthcare, will today speak on a panel discussion on “The private sector’s role in Russia’s evolving healthcare future” at the St Petersburg International Economic Forum (“SPIEF”) at 17:15 (MSK) in Pavilion 3, Amphitheatre.
During the event, Dr Kurtser will share his views on current business trends and prospects for the healthcare services sector in Russia, emphasising how the private sector has become increasingly involved in the Russian healthcare system, and, what the State is doing to create favourable conditions to promote the development of the healthcare sector.
Dr Kurtser will highlight key measures that are making private sector healthcare investment more attractive including zero income tax until 2020. In addition he will draw attention to potential measures that will enable companies to invest in new technology and enhance the quality of medical services available to people across Russia.
SPIEF is attended by leading politicians, businessmen, bankers and other guests associated with business in Russia and is commonly known as “The Russian Davos”.
No material information will be disclosed at the event.
For further information please contact:
|
Investors |
Media |
|
Elena Romanova MD Medical Group Investments Plc |
EM |
|
|
Consilium Strategic Communications |
About MD Medical Group
MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 17 modern healthcare facilities, including 2 hospitals and 15 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk and Yaroslavl. In addition, 3 franchised outpatient clinics operate in Kyiv, Ukraine.
The Company's main medical facilities are the Perinatal Medical Center (PMC), a 250-bed medical centre, which opened its doors in 2006, and Lapino hospital, a 182-bed medical centre, which opened at the end of 2012. In 2013, there were 3,816 deliveries in PMC and Lapino. The number of outpatient treatments for 2013 in PMC and the Company's outpatient clinics totalled 627,247. In March 2013, the Company began construction of its third hospital in Ufa. In April 2013 MD Medical Group completed the acquisition of the IDK Medical Company ("IDK"), a network of women's and children's health clinics located in the Russian region of Samara. In May 2013, the Company acquired Mother&Child clinic in Irkutsk, which had previously operated through a franchise agreement with MD Medical Group. The same month the Company completed a large-scale modernisation project of its Mother & Child Health Clinic in Moscow. In December 2013, a new outpatient clinic was opened in Yaroslavl which became the first healthcare facility in the region to provide IVF services.
The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.